SMTL ID : 9n3m.1

SARS-CoV-2 Mpro L50F/E166A/L167F triple mutant bound to inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

homo-dimer

Ligands

2 x 01: (1S,2S,4S)-2-{[3-cyclopropyl-N-(4-methoxy-1H-indole-2-carbonyl)-L-alanyl]amino}-1-hydroxy-4-methyl-5-(methylamino)-5-oxopentane-1-sulfonic acid

01.1: 16 residues within 4Å: Chain A: H.41, F.140, L.141, N.142, G.143, S.144, C.145, H.163, H.164, M.165, A.166, P.168, D.187, R.188, Q.189, T.190 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:D.187, A:Q.189 Hydrogen bonds: A:F.140, A:G.143, A:S.144, A:C.145, A:H.164, A:A.166 01.2: 16 residues within 4Å: Chain B: H.41, F.140, L.141, N.142, G.143, S.144, C.145, H.163, H.164, M.165, A.166, P.168, D.187, R.188, Q.189, T.190 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:D.187, B:Q.189 Hydrogen bonds: B:F.140, B:G.143, B:S.144, B:C.145, B:H.164, B:A.166

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fischer, C. et al., Structural insights into the nirmatrelvir-resistant SARS-CoV-2 M pro L50F/E166A/L167F triple mutant-inhibitor-complex reveal strategies for next generation coronaviral inhibitor design. Rsc Med Chem (2025)

Release Date

2025-08-20

Peptides

3C-like proteinase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

3C-like proteinase

Related Entries With Identical Sequence